A single antibody could be the key to treating multiple
myeloma, or cancer of the blood, currently without cure or long-term treatment.
“We tested the antibody in various ways, including on tumour
cells from myeloma patients that have been transplanted into mice. The tests
showed that the antibody is able to destroy myeloma cells”, explains Markus
Hansson, a researcher at Lund University in Sweden.